Sedana Medical reaches an important milestone – The first patient in Asia is treated with AnaConDa.
Sedana Medical AB’s (“Sedana Medical”) product AnaConDa is used in South Korea and Asia for the first time. South Korea is the first country in Asia to approve, launch and use AnaConDa for inhalation sedation of mechanically ventilated patients in intensive care units.AnaConDa received approval from the South Korean authority K-FDA earlier in 2017, making South Korea the first market in Asia to approve the AnaConDa technology. Sedana Medical had previously signed an exclusive contract with the South Korean distributor DaeSeuk Med Co. Ltd. concerning the rights to market and sell AnaConDa to